Predictivity of dog co-culture model, primary human hepatocytes and HepG2 cells for the detection of hepatotoxic drugs in humans

被引:43
作者
Atienzar, Franck A. [1 ]
Novik, Eric I. [2 ]
Gerets, Helga H. [1 ]
Parekh, Amit [2 ]
Delatour, Claude [1 ]
Cardenas, Alvaro [1 ]
MacDonald, James [3 ]
Yarmush, Martin L. [4 ]
Dhalluin, Stephane [1 ]
机构
[1] UCB Pharma SA, Nonclin Dev, B-1420 Braine Lalleud, Belgium
[2] H Rel Corp, North Brunswick, NJ 08902 USA
[3] Chrysalis Pharma Consulting LLC, Chester, NJ 07930 USA
[4] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA
关键词
Hepatotoxicity; Metabolism; Chronic studies; Dog co-culture model; Primary human hepatocytes; HepG2; cells; INDUCED LIVER-INJURY; IN-VITRO; HEPATIC-CLEARANCE; HEPARG CELLS; LABEL-FREE; METABOLISM; TOXICITY; ASSAY; PHARMACOKINETICS; CYTOTOXICITY;
D O I
10.1016/j.taap.2013.11.022
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Drug Induced Liver Injury (DILI) is a major cause of attrition during early and late stage drug development. Consequently, there is a need to develop better in vitro primary hepatocyte models from different species for predicting hepatotoxicity in both animals and humans early in drug development. Dog is often chosen as the non-rodent species for toxicology studies. Unfortunately, dog in vitro models allowing long term cultures are not available. The objective of the present manuscript is to describe the development of a co-culture dog model for predicting hepatotoxic drugs in humans and to compare the predictivity of the canine model along with primary human hepatocytes and HepG2 cells. After rigorous optimization, the dog co-culture model displayed metabolic capacities that were maintained up to 2 weeks which indicates that such model could be also used for long term metabolism studies. Most of the human hepatotoxic drugs were detected with a sensitivity of approximately 80% (n = 40) for the three cellular models. Nevertheless, the specificity was low approximately 40% for the HepG2 cells and hepatocytes compared to 72.7% for the canine model (n = 11). Furthermore, the dog co-culture model showed a higher superiority for the classification of 5 pairs of close structural analogs with different DILI concerns in comparison to both human cellular models. Finally, the reproducibility of the canine system was also satisfactory with a coefficient of correlation of 75.2% (n = 14). Overall, the present manuscript indicates that the dog co-culture model may represent a relevant tool to perform chronic hepatotoxicity and metabolism studies. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:44 / 61
页数:18
相关论文
共 72 条
[1]
Kinetic Cell-Based Morphological Screening: Prediction of Mechanism of Compound Action and Off-Target Effects [J].
Abassi, Yama A. ;
Xi, Biao ;
Zhang, Wenfu ;
Ye, Peifang ;
Kirstein, Shelli L. ;
Gaylord, Michelle R. ;
Feinstein, Stuart C. ;
Wang, Xiaobo ;
Xu, Xiao .
CHEMISTRY & BIOLOGY, 2009, 16 (07) :712-723
[2]
Äbelö A, 2000, DRUG METAB DISPOS, V28, P966
[3]
Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells [J].
Atienzar, Franck ;
Gerets, Helga ;
Dufrane, Simon ;
Tilmant, Karen ;
Cornet, Miranda ;
Dhalluin, Stephane ;
Ruty, Bernard ;
Rose, Geoffrey ;
Canning, Michael .
TOXICOLOGICAL SCIENCES, 2007, 96 (01) :101-114
[4]
The Use of Real-Time Cell Analyzer Technology in Drug Discovery: Defining Optimal Cell Culture Conditions and Assay Reproducibility with Different Adherent Cellular Models [J].
Atienzar, Franck A. ;
Tilmant, Karen ;
Gerets, Helga H. ;
Toussaint, Gaelle ;
Speeckaert, Sebastien ;
Hanon, Etienne ;
Depelchin, Olympe ;
Dhaluin, Stephane .
JOURNAL OF BIOMOLECULAR SCREENING, 2011, 16 (06) :575-587
[5]
Evaluation of Impedance-Based Label-Free Technology as a Tool for Pharmacology and Toxicology Investigations [J].
Atienzar, Franck Andre ;
Gerets, Helga ;
Tilmant, Karen ;
Toussaint, Gaelle ;
Dhalluin, Stephane .
BIOSENSORS-BASEL, 2013, 3 (01) :132-156
[6]
Barkin Robert L, 2007, Am J Ther, V14, P299, DOI 10.1097/MJT.0b013e31804c7292
[7]
Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver [J].
Begriche, Karima ;
Massart, Julie ;
Robin, Marie-Anne ;
Borgne-Sanchez, Annie ;
Fromenty, Bernard .
JOURNAL OF HEPATOLOGY, 2011, 54 (04) :773-794
[8]
Commentary on 'case series of liver failure associated with rosiglitazone and pioglitazone' by James Floyd et al. [J].
Beiderbeck, Annette B. ;
Sakaguchi, Motonobu .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (12) :1247-1249
[9]
Predicting safety toleration of pharmaceutical chemical leads: Cytotoxicity correlations to exploratory toxicity studies [J].
Benbow, John W. ;
Aubrecht, Jiri ;
Banker, Michael J. ;
Nettleton, David ;
Aleo, Michael D. .
TOXICOLOGY LETTERS, 2010, 197 (03) :175-182
[10]
BETAXOLOL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN HYPERTENSION [J].
BERESFORD, R ;
HEEL, RC .
DRUGS, 1986, 31 (01) :6-28